NASDAQ:CRNX | Free Cash Flow | Crinetics Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2016-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$124.7M$820,000.00-$125.52M
2025-12-31-$92.9M$458,000.00-$93.36M
2025-03-31-$88.45M$1.24M-$89.69M
2024-12-31-$66.87M$1.03M-$67.9M
2024-03-31-$52.86M$1.33M-$54.19M
2023-12-31-$40.81M$935,000.00-$41.74M
2023-03-31-$40.72M$16,000.00-$40.73M
2022-12-31-$35.21M$274,000.00-$35.48M
2022-03-31-$13.54M$87,000.00-$13.63M
2021-12-31-$22.9M$18,000.00-$22.92M
2021-03-31-$20.07M$116,000.00-$20.18M
2020-12-31-$15.94M$17,000.00-$15.96M
2020-03-31-$12.23M$60,000.00-$12.29M
2019-12-31-$13.45M$28,000.00-$13.48M
2019-03-31-$6.76M$408,000.00-$7.17M
2018-12-31-$6.01M$282,000.00-$6.29M
2018-03-31-$3.41M$57,000.00-$3.46M
2017-12-31-$2.51M$231,000.00-$2.74M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$377.92M$5.76M-$383.68M
2024-12-31-$230.19M$3.84M-$234.04M
2023-12-31-$168.6M$4.69M-$173.29M
2022-12-31-$115.21M$1.66M-$116.86M
2021-12-31-$88.59M$436,000.00-$89.02M
2020-12-31-$62.03M$186,000.00-$62.21M
2019-12-31-$46.38M$492,000.00-$46.87M
2018-12-31-$19.46M$1.06M-$20.52M
2017-12-31-$9.48M$304,000.00-$9.78M
2016-12-31-$5.47M$190,000.00-$5.66M